Japan start-up Innophys Co. is expanding overseas in nations that have aging populations to offer its wearable exoskeleton to support heavy lifting.
Set up by Tokyo University of Science professor Hiroshi Kobayashi, Innophys Co, hopes its products will be used in the care and farm fields in Europe, China, and South Korea, where similar age-related social issues occue.
Innophys Executive Officer Masaru Yoda said that with demand for assistive suits getting greater as populations age, they have a chance at being top in the world.
The firm has a domestic market share of about 70 percent. It sold around 20,000 Muscle Suit in April 2021 since launching it in 2014.
The exoskeletons support the arms and back.
They employ artificial muscles that are composed of rubber tubes covered in nylon mesh that expand when compressed air is added, creating a strong pulling force that can help with physically demanding manual activities and lessen back strain when lifting large goods.
The suit, which is worn like a backpack, can greatly reduce stress when performing heavy factory work, caregiving, and agricultural duties. It is also a useful tool for averting potential workplace mishaps.
Each item costs about 150,000 yen and weighs about 4 kg.
In 2020, Innophys began to expand into Taiwan, Hong Kong, and Macao. Currently, the company has sales representatives in 17 nations and areas, including China, South Korea, Germany, and France.


Chinalco and Rio Tinto Acquire Controlling Stake in Brazil’s CBA for $903 Million
Astronomers have discovered another puzzling interstellar object − this third one is big, bright and fast
U.S. and Rwanda Sign $228 Million Health Partnership to Boost Self-Reliance
NASA and Roscosmos Chiefs Meet in Florida to Discuss Moon and ISS Cooperation
Disney Board Nears CEO Decision as Josh D’Amaro Emerges as Leading Candidate
China Manufacturing PMI Slips Into Contraction in January as Weak Demand Pressures Economy
Asian Markets Slide as Silver Volatility, Earnings Season, and Central Bank Meetings Rattle Investors
FDA Lifts REMS Requirement for CAR-T Cell Cancer Therapies
Starmer’s China Visit Highlights Western Balancing Act Amid U.S.-China Rivalry
South Korea Factory Activity Hits 18-Month High as Export Demand Surges
Nvidia’s $100 Billion OpenAI Investment Faces Internal Doubts, Report Says
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
Novo Nordisk Launches Once-Daily Wegovy Pill in U.S. at Competitive Pricing
Why Trump’s new pick for Fed chair hit gold and silver markets – for good reasons
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions 



